To provide new insights into the in vivo regulation of iodothyronine deiodinases in the different tissues of the rat, we have evaluated the effects on these enzymatic activities of T 4 or T 3 infusions into thyroidectomized rats.
animals infused with T 3 alone despite normal tissue T 3 concentrations. Cortex type III 5-deiodinase was only increased when hyperthyroidism was induced by infusion of T 3 . Liver type I 5Ј-deiodinase (DI) paralleled the changes in plasma and tissue T 3 regardless of whether T 4 or T 3 was infused. On the contrary, the increase in lung DI, proportional to the increases in plasma and tissue T 3 , was higher when T 4 was infused. As a rule, the tissues with DII presented a tighter homeostasis in their T 3 concentrations than the tissues with DI.
In conclusion, the regulation of iodothyronine deiodinases depends on the hormone infused into the thyroidectomized animals and on the tissue in which the deiodinase is studied, demonstrating the existence of tissue-specific regulation of its thyroid hormone concentrations. (Endocrinology 138: 2559 -2568, 1997) T HE METABOLISM of thyroid hormones is mediated by several enzymatic reactions, including conjugation, deamination, oxidative decarboxylation, and deiodination, which is the predominant mechanism (1). Deiodination of T 4 at the 5Ј-position of the phenolic ring can be considered a bioactivation, as the affinity of the nuclear thyroid hormone receptor for the resulting T 3 is 10-to 20-fold the affinity for T 4 (1) (2) (3) (4) . On the contrary, deiodination of T 4 at the 5-position of the tyrosyl ring results in an inactivation, as the resulting rT 3 has very low affinity for nuclear thyroid hormone receptors. Thus, deiodination is a key step in the regulation of thyroid hormone action, as approximately 80% of the T 4 secreted by the thyroid gland is deiodinated (5) either into the most active thyroid hormone, T 3 , or into an inactive iodothyronine, rT 3 . Deiodination is also involved in the main route of degradation of iodothyronines (i.e. inner ring deiodination of T 3 ) and plays a crucial role in the catabolism of sulfate conjugates of T 4 and T 3 in the liver (6) . Thus, deiodination must not be considered an isolated event in thyroid hormone metabolism, but, rather, a highly regulated step that is coordinated with other metabolic reactions in several tissues.
Three major patterns of deiodination have been identified based on the activity measurements of tissue homogenates (7) , which, according to affinity labeling studies, correspond to three separate enzymes (8 -10) , termed types I, II, and III iodothyronine deiodinases (DI, DII, and DIII). The genes responsible for these enzymes in several species have recently been cloned (11) (12) (13) (14) (15) . Although the overall similarity of these genes is relatively low, there are three highly conserved limited regions, including a TGA codon that codes for selenocystein, which is essential for catalytic activity (15, 16) .
DI can catalyze 5Ј-deiodination of nonsulfated iodothyronine, such as T 4 and rT 3 , or the 5-deiodination of sulfated conjugates of T 4 or T 3 (T 4 S and T 3 S) (6, 17) , and is extremely sensitive to inhibition by 6-propyl-2-thiouracil (PTU) and aurothioglucose (2) . DI activity is found in liver, kidney, lung, pituitary gland, and thyroid (18, 19) . Its affinity is higher for rT 3 , T 4 S, and T 3 S than for T 4 , and its role in liver, lung, and kidney seems to be the 5Ј-deiodination of rT 3 and the 5-deiodination of iodothyronine sulfates (20) , whereas in the human and rat thyroid it catalyzes the 5Ј-deiodination of T 4 to T 3 (2) under the influence of TSH stimulation (21) .
DII is present in the central nervous system, brown adipose tissue (BAT), anterior pituitary, and placenta (22) (23) (24) (25) . This enzyme is relatively insensitive to PTU, and its affinity is higher for T 4 than for rT 3 . Brain DII has a primordial role in ensuring the adequate intracellular concentration of T 3 in the brain during critical periods of development in fetal and neonatal rats (26 -28) . In a recent study, we have also shown that increased DII activity in hypothyroid adult rats is able to normalize brain T 3 concentrations when T 4 is infused at very low doses that are insufficient to normalize even plasma T 4 and T 3 concentrations (29) , providing a sensitive mechanism for maintaining brain T 3 homeostasis (27, 30) . BAT DII significantly contributes to maintain T 3 concentrations in that tissue (31, 32) , explaining the important role of T 3 in the full thermogenic response to cold exposure (33) . Finally, pituitary DII contributes significantly to the T 3 that reaches the nuclear receptor, explaining how pituitary function can be modulated by circulating T 4 as well as by circulating T 3 (34) .
DIII is resistant to PTU and aurothioglucose, and its affinity is higher for T 3 than for T 4 (2), catalyzing their conversion to 3Ј,3-T 2 and rT 3 , respectively. This enzyme is present in brain, skin, placenta, and fetal tissues of the rat (35) (36) (37) . This distribution suggests that DIII may have protective properties against high thyroid hormone concentrations during fetal development (2) .
The regulation of deiodinase activity involves both preand posttranslational mechanisms and occurs in a tissue-and enzyme-specific manner (2) . Although several factors, such as cold, fasting, cytokines, GH, retinoids, and drugs, influence deiodinase activity (16, 38) , the main regulator is thyroid status. Hypothyroidism results in an increased activity of DII and thyroid DI and a decreased activity of liver and kidney DI and DIII. Opposite changes are noted in hyperthyroidism (1) . It is well known that T 3 stimulates DI messenger RNA and activity in nearly all tissues studied (11, 39 -42) , and that thyroid hormones exert rapid inhibitory effects on DII (30) .
Most previous pioneering studies have explored the regulation of the different iodothyronine deiodinases under conditions of severe hypo-or hyperthyroidism as well as their responses to injections of T 4 or T 3 . This methodology does not permit exploration of the relationships between enzyme activities and concentrations of iodothyronines in serum or different tissues, as the time courses of possible changes in T 4 or T 3 concentrations and in the activities of the different deiodinases might differ both within the same tissue and among tissues. In the present study this problem was obviated by administering T 4 or T 3 by constant infusion, so that the different tissues would be in a steady state situation with regard to both the concentration of iodothyronines and the activities of the enzymes. As will be seen, the results provided new insights into the in vivo regulation of iodothyronine deiodinases in various tissues of the rat, and their consequences for the homeostasis of tissue thyroid hormone concentrations.
Materials and Methods

Experimental design
Young female Wistar rats, 120 -150 g BW, were surgically thyroidectomized and received 100 Ci 131 I, ip, 1 week later. After 28 days, rats with complete body weight stasis were divided into groups of six rats each, and osmotic minipumps (Alzet, model 2ML2, Alza Corp., Palo Alto, CA) were implanted under the dorsal skin of the animals. In three separate experiments, the rats were infused with placebo solution, T 4 (Exp A: 1.0, 2.0, 3.0, 4.0, and 8.0 g/100 g BW⅐day; Exp B: 0.2, 0.4, 0.6, 0.8, and 1.6 g/100 g BW⅐day), or T 3 (Exp C: 0.25, 0.50, 0.75, 1.00, and 2.00 g/100 g BW⅐day). One group of seven nonthyroidectomized rats, matched for sex and age and infused with placebo, served as the control euthyroid group in each experiment.
After 12-13 days of infusion the rats were bled and perfused, as previously described (29) , after being slightly anesthetized with ether. Samples of plasma, cerebral cortex, pituitary, BAT, liver, lung, and other tissues were obtained for the present and other studies. Samples were immediately frozen on dry ice and stored at Ϫ20 C until analyzed, with the exception of aliquots of cortex, pituitary, BAT, liver, and lung that were stored at Ϫ80 C for measurement of iodothyronine deiodinase activity. The thyroid hormone tissue and plasma concentrations as well as some preliminary data for deiodinase activities of T 4 -infused rats were previously reported (29) .
Determinations
T 4 and T 3 were measured in whole plasma and in tissues after extraction and purification of the iodothyronines by specific and highly sensitive RIAs, as detailed previously (29, 43) .
TSH was measured in plasma using immunoreactants kindly provided by the Rat Pituitary Agency of the NIDDK, NIH (Bethesda, MD), as described previously (29, 43) . Results are expressed in weight equivalents of the NIDDK rTSH RP-3 preparation.
DII activity was assayed in cortex and BAT (31) using 2 nm T 4 , 1 m T 3 , and 20 mm dithiothreitol (DTT) in the presence of 1 mm PTU, and the reaction time was 60 min. DI activity was assayed in liver, pituitary, and lung homogenates as previously described (26) , using 400 nm rT 3 and 2 mm DTT for liver, and 2 nm rT 3 and 20 mm DTT for pituitary and lung, in 100 mm potassium phosphate buffer (pH 7.0). The reaction time was 10 min for liver and 60 min for pituitary and lung. Pituitary DII activity was evaluated using 2 nm rT 3 Ϫ released was separated by ion exchange chromatography on Dowex 50W-X2 (BioRad, Richmond, CA) columns equilibrated in 10% acetic acid. The production of equal amounts of iodide and 3Ј,3-diiodothyronine was checked in some assays. The protein content was determined as previously described (26, 27, 31) after precipitation of the homogenates with 10% trichloroacetic acid to avoid interference from DTT in the colorimetric reaction.
DIII activity was measured in cortex homogenates (29) , incubating 20 -50 g protein/100 l in 100 mm potassium phosphate buffer (pH 7. 
Statistical analysis
One-way ANOVA and the protected least significant difference test for multiple comparisons were used after validation of the homogeneity of variances by the Bartlett-Box F test. Square root or logarithmic transformations usually ensured homogeneity of variances when this was not found with the raw data. Results are expressed as the mean Ϯ sem. P Ͻ 0.05 was considered significant in all comparisons. To compare the results from the three experiments and to compare the degree of change observed in the plasma with those in various tissues, iodothyronine deiodinase activity and T 4 , T 3 , and TSH concentrations in samples from each thyroidectomized rat and from each thyroidectomized rat receiving different T 4 or T 3 doses are expressed in the figures as percentages of the mean value corresponding to the group of intact controls, which was taken as 100%.
To assess the relationships between tissue and plasma T 3 and T 4 concentrations and deiodinase activity, individual paired data, expressed as percentages of the mean value of the group of intact controls, as stated above, were adjusted to several curves (linear, logarithmic, inverse, compound, power, sigmoidal, growth, and exponential). The curve fit with the highest coefficient of determination (r 2 ), degrees of freedom, and F statistics was selected for each variable. When T 3 alone was used as replacement therapy for hypothyroidism, the plasma T 4 concentration was not included in the curve fitting because its values were below the limit of detection of our assay in all groups of thyroidectomized rats (plasma T 4 resulted in a constant rather than a variable). Curve fittings with r 2 Ͻ 0.50, despite statistical significance, are usually not considered of biological significance, as in such a case less than 50% of the changes in the dependent variables are explained by related changes in the independent variable. Statistical analyses were performed with the SPSS for Macintosh versions 4.0 and 6.1.1 (SPSS, Chicago, IL).
Results
The iodothyronine deiodinase activities, as a function of the dose of T 4 or T 3 infused, are described in Table 1 Table 2 .
Plasma concentrations of thyroid hormones
In the thyroidectomized rats infused with placebo the plasma concentrations of T 4 and T 3 were very low, and the concentrations of TSH were very high ( Fig. 1 ). In the rats infused with T 4 , normal plasma T 4 concentrations were reached in the groups infused with 0.6 -1.0 g/100 g BW⅐day, normal plasma T 3 concentrations were obtained in the groups infused with 1.0 and 1.6 g/100 g BW⅐day, and both increased above normal at higher T 4 doses (Fig. 1) . Plasma TSH concentrations were normal only in the group infused 1 To permit comparisons between the different experiments, the thyroid hormone concentrations are expressed in the figures as percentages of the mean values of the control group. The absolute values of plasma and tissue thyroid hormone concentrations and plasma TSH concentrations in T 4 -infused rats were described in detail previously (29) . The absolute values of plasma and tissue thyroid hormone concentrations and plasma TSH concentrations in T 3 -infused rats can be derived from the data points shown in Figs. 1-4 , where the 100% values corresponding to the placebo-infused control group of Exp C were: plasma T 4 , 40 Ϯ 2 ng/ml; plasma T 3 , 0.79 Ϯ 0.08 ng/ml; plasma TSH, 0.89 Ϯ 0.12 ng/ml; cerebral cortex T 4 , 1.73 Ϯ 0.25 ng/g; cerebral cortex T 3 , 2.67 Ϯ 0.14 ng/g; BAT T 4 
Cortex, cerebral cortex; BAT, brown adipose tissue. a The doses are in micrograms per 100 g BW/day. b The symbols represent the comparison of the mean values from T 4 -or T 3 -infused rats with those from control rats infused with placebo: ϭ indicates that there were no statistically significant differences; and Ń identifies low levels compared to controls, with at least P Ͻ 0.05; ł identifies elevated levels compared to controls, with at least P Ͻ 0.
05. An open arrow (ņ or Ň) indicates that, although statistically significant, the change with respect to controls was relatively small, within Ϯ30% of the mean of the control group. with 1.6 g/100 g BW⅐day; plasma TSH levels were elevated in the groups infused with lower T 4 doses and decreased in the groups infused with higher T 4 doses (Fig. 1) .
Plasma T 4 concentrations were below the limit of detection of the assay in all groups of thyroidectomized rats infused with T 3 (Fig. 1 ). Plasma T 3 was already normal in the group infused with 0.25 g/100 g BW⅐day and elevated in the groups infused with higher T 3 doses (Fig. 1) . Finally, the plasma TSH concentration was elevated in the group infused with 0.25 g/100 g BW⅐day and low in the groups infused with higher T 3 doses (Fig. 1) .
Cerebral cortex DII
Cerebral cortex DII activity was markedly elevated in thyroidectomized rats infused with placebo (Table 1 and Fig. 2 ). When T 4 was infused into thyroidectomized rats, cortex DII activity showed a progressive decrease, reaching normal activities with T 4 doses between 0.6 -3.0 g/100 g BW⅐day, whereas the groups infused with the higher T 4 doses (4.0 and 8.0 g/100 g BW⅐day) showed decreased DII activity with respect to controls ( Table 1 and Fig. 2 ). Cerebral cortex T 3 concentrations reached normal levels with T 4 doses from 0.4 -8.0 g/100 g BW⅐day, with the exception of a slight increase in the group infused with 1.6 g/100 g BW⅐day (Fig.  2) . On the contrary, cortex T 4 concentrations were low in the groups infused with 0.2-0.8 g/100 g BW⅐day and high in the groups infused with 1.0 -8.0 g/100 g BW⅐day (Fig. 2) .
In contrast to the result of infusion of T 4 alone, when T 3 was infused into thyroidectomized rats, cortex DII activity remained elevated, as none of the doses of T 3 infused was able to normalize its activity. Moreover, DII activity was further increased, compared to the activities found in animals infused with placebo, with T 3 doses of 0.25, 0.50, and 0.75 g/100 g BW⅐day (Table 1 and Fig. 2 ). Cerebral cortex T 3 concentrations reached normal levels in the group infused with 0.75 and 1.00 g/100 g BW⅐day and were elevated with the higher T 3 dose (Fig. 2) . As expected, cerebral cortex T 4 concentrations were low in all groups infused with T 3 (Fig.  2) .
DII activity in the cerebral cortex of rats infused with T 4 was related to both plasma and cortex T 4 and T 3 (Fig. 5) . In the rats infused with T 3 , DII activity was only related to cortex T 4 and plasma T 3 , but the curve fittings were not strong enough (r 2 Ͻ 0.50) to ensure biological significance (Fig. 5) .
Cerebral cortex DIII
DIII activity in cerebral cortex showed inconsistent results in the groups infused with placebo, as this activity was reduced with respect to that in the control group only in Exp A, but remained normal in Exp B and C (Table 1 ). In the groups infused with T 4 , cerebral cortex DIII activity was not different from the control value, and the small changes present between the groups infused with different T 4 doses were not related to the changes in cortex T 4 or T 3 levels (Table  1) .
On the contrary, in the animals infused with T 3 alone, DIII activity increased with the higher T 3 doses and higher cortex T 3 concentrations (Table 1 and Fig. 2) . In this experiment, the changes in DIII activity were weakly related to the changes in cortex and plasma T 3 (compound curve fitting: r 2 ϭ 0.43; P Ͻ 0.01; power curve fitting: r 2 ϭ 0.37; P Ͻ 0.01).
BAT DII
BAT DII activity was markedly elevated in thyroidectomized rats infused with placebo (Table 1 and Fig. 2 ). When T 4 was infused, DII activity showed an irregular pattern of response, showing a tendency to normalization with the higher T 4 doses (Table 1 and Fig. 2) . BAT showed an acceptable homeostasis in its T 3 concentrations, which were normal in all groups infused with T 4 , with the exception of low levels in the groups infused with 0.2, 0.4, and 1.6 g/100 g BW⅐day (Fig. 2) . As occurred with BAT DII activity, the changes in BAT T 4 concentrations were highly irregular. These T 4 values might be questioned because of the proximity of the interscapular BAT pads to the site where the osmotic pump is implanted and from which it is only separated by an easily punctured, thin layer of connective tissue. Although care was taken at autopsy to avoid contact between the BAT pads and fluid surrounding the T 4 -containing pumps, some external contamination with T 4 might have occurred; for this reason the data have not been shown.
BAT DII activity decreased when T 3 was infused into thyroidectomized rats, but its activity did not reach normal values at any of the T 3 doses tested (Table 1 and Fig. 2 ), although BAT T 3 concentrations were normal in the groups infused with 0.75 g/100 g BW⅐day or more (Fig. 2) . As expected, T 4 concentrations were very low in all groups of thyroidectomized rats infused with T 3 (Fig. 2) .
BAT DII activity in thyroidectomized rats receiving T 4 alone showed sigmoidal relationships to plasma T 3 and T 4 (Fig. 5) . Curve fitting of BAT DII activity against tissue and plasma T 4 and T 3 concentrations disclosed only weak relationships in rats infused with T 3 (Fig. 5) .
Pituitary DII and DI
Pituitary DII activity was markedly elevated, and DI activity was markedly decreased, in thyroidectomized rats infused with placebo (Table 1 and Fig. 3 ).
The effects of T 4 infusion on pituitary 5Ј-deiodinase activities were evaluated only in Exp B, as, unfortunately, no aliquots of pituitary homogenate were saved before extraction in Exp A. Pituitary DII activity showed a progressive decrease with the increasing T 4 doses infused, reaching normal values with the dose of 1.6 g/100 g BW⅐day (Table  1 and Fig. 3 ). Pituitary DI activity showed the opposite change, increasing with the increasing T 4 doses, but remained slightly decreased (81% of the mean value of the control group) with respect to the control value with the higher dose of 1.6 g/100 g BW⅐day (Table 1 and Fig. 3 ). Pituitary T 4 concentrations were low in the group infused with 0.2 g/100 g BW⅐day; normal in the groups infused with 0.4, 0.6, 1.0, and 2.0 g/100 g BW⅐day; and elevated in the groups infused with 0.8, 1.6, and 3.0 -8.0 g/100 g BW⅐day (Fig. 3) . Pituitary T 3 concentrations reached normal levels in the groups infused with T 4 doses ranging from 1.0 -3.0 g/100 g BW⅐day and were elevated in those given higher T 4 doses (Fig. 3) .
When the animals were infused with T 3 , the changes in pituitary DII activity resembled those in BAT. Although there was a progressive decrease in DII activity, it remained elevated in the group infused with the higher T 3 dose (Table  1 and Fig. 3 ). On the contrary, pituitary DI activity reached normal levels in the groups infused with 0.25 and 0.50 g/ 100 g BW⅐day and was elevated with higher T 3 doses (Table  1 and Fig. 3 ). Pituitary T 3 reached normal concentrations in the groups infused with 0.50 and 0.75 g/100 g BW⅐day and was elevated with higher T 3 doses (Fig. 3) . As expected, pituitary T 4 concentrations were low in all groups infused with T 3 (Fig. 3) .
Finally, both pituitary DI and DII activities in thyroidectomized rats given T 4 alone were related to pituitary and plasma T 4 and T 3 (Fig. 6) , and the best fit was obtained for both deiodinases with pituitary T 4 . On the contrary, when the animals were infused with T 3 alone, pituitary DI and DII activities were only related to plasma and pituitary T 3 (Fig. 6) . 
Liver DI
Liver DI activity was markedly decreased in thyroidectomized rats infused with placebo (Table 1 and Fig. 4 ). In the rats infused with T 4 , liver DI activity reached normal levels with 1.0 and 1.6 g/100 g BW⅐day and was elevated with higher T 4 doses ( Table 1 and Fig. 4) . The changes in liver DI activity paralleled closely those in plasma T 3 , whereas the concordance with liver T 3 and T 4 was not complete (Table 1 and Fig. 4) . Liver DI activity in rats infused with T 4 was related to plasma T 4 and T 3 and to liver T 3 and T 4 (Fig. 7) .
Liver DI activity was increased in all groups infused with T 3 , showing some concordance with liver T 3 ( Table 1 and Fig.  4 ). Liver DI activity was related to plasma and liver T 3 and, surprisingly, to liver T 4 ( Fig. 7) , although the latter concentrations were extremely low (Fig. 4) .
Lung DI
Lung DI activity was markedly decreased in thyroidectomized rats infused with placebo (Table 1 and Fig. 4 ). In the rats infused with T 4 , lung DI activity reached a normal value with 1.0 -3.0 g/100 g BW⅐day (the dispersion in the lung DI activity of the control group was high) and was elevated with higher T 4 doses (Table 1 and Fig. 4) . The changes in lung DI activity paralleled those in lung T 3 (Fig. 4) and were mainly related to plasma and lung T 3 and, to a lesser degree, plasma and lung T 4 (Fig. 7) .
When T 3 was infused into thyroidectomized rats, lung DI activity was normal with the dose of 0.25 g/100 g BW⅐day and elevated with higher T 3 doses (Table 1 and Fig. 4) . Similar changes were observed in lung T 3 concentrations, whereas lung T 4 levels were very low (Fig. 4) . Lung DI activity was related to plasma and lung T 3 (Fig. 7) .
Relationships between plasma TSH concentration and iodothyronine deiodinase activities
Cerebral cortex and BAT DII activity showed weak or nonsignificant relationships with plasma TSH concentrations regardless of whether T 4 or T 3 was infused into thyroidectomized rats (Table 2) . On the contrary, the changes in pituitary DII activity and in pituitary, liver, and lung DI activities were related to the changes in plasma TSH concentrations (Table 2 ). Pituitary DII activity was directly related to TSH, as expected from the fact that both increase in response to hypothyroidism, whereas DI activity in pituitary, liver, and lung, was inversely related to the change in plasma TSH, reflecting the expected opposite response to the change in thyroid function (Table 2) . Finally, the change in cerebral cortex DIII in the animals infused with T 3 alone showed a weak, but significant, relationship with plasma TSH (Table  2) .
Discussion
Thyroidal status is the main regulator of iodothyronine deiodinase activity. DII activity increases in response to hypothyroidism (30) and decreases in response to hyperthyroidism. On the contrary, DI activity decreases in hypothyroid situations and increases in hyperthyroidism, with the exception of the thyroidal enzyme, which is under the control of plasma TSH (21) . Our results show that the degree of response of each enzyme to thyroidal status is different depending on the tissue studied and the hormone infused.
Type II 5Ј-deiodinase and type III 5-deiodinase
As expected, DII activity is increased in cerebral cortex, BAT, and pituitary in thyroidectomized animals infused with placebo. In the three tissues studied, DII activity decreases in response to T 4 infusion, reaching normal levels after tissue T 3 euthyroidism is reached. However, when T 3 is infused, DII activity does not normalize even in the presence of normal or high tissue T 3 concentrations. In contrast to BAT and pituitary DII, which tended to decrease with the increase in T 3 concentrations, cerebral cortex DII activity actually increases in this situation. Recent results from our group have shown a similar T 3 -induced increase in DII activity in fetal BAT (44) . Present results point to T 4 , but not T 3 , as the main down-regulator of cerebral cortex and BAT DII activity (27, 29) . Moreover, the tight tissue homeostasis of the T 3 concentration in the cerebral cortex and BAT is only maintained when T 4 is supplied to the thyroidectomized animals, further suggesting that DII activity and T 4 are intimately related, with the former using the latter as substrate to provide T 3 , especially in hypothyroid situations. Finally, although a stimulatory effect of TSH on DII expression has been described in astrocytes (45) , our data have failed to confirm this hypothesis, as the changes in cortex DII activity in rats infused with T 3 did not shown any relationship with changes in plasma TSH.
Pituitary DII activity showed a different pattern of response to T 4 infusion compared to DII in the cortex and BAT. Pituitary DII needed elevated pituitary T 4 concentrations and normal pituitary T 3 concentrations to normalize its activity. This result might be related to the presence of DI activity in pituitary, as the T 3 produced from T 4 by pituitary DI might be exported into the circulation instead of contributing to local T 3 concentrations. In fact, a similar physiological role has been suggested for DI activity in other tissues, such as liver and kidney (2) . In contrast to the cerebral cortex and BAT enzymes, pituitary DII activity showed a strong relationship with pituitary and plasma T 3 during T 3 infusion, a result that suggests that at least to some extent in the pituitary, DII activity is sensitive to the inhibitory effects of T 3 . This conclusion is also supported by others using single iodothyronine injections in vivo (46) . Unfortunately, we were not able to measure pituitary iodothyronine deiodinase activities in Exp A, and thus, we do not have data regarding the pattern of response of these activities in T 4 -induced hyperthyroidism.
When hyperthyroidism was induced by infusion of very high doses of T 4 or T 3 , cerebral cortex DII activity only showed a mild decrease with T 4 infusion and remained elevated when T 3 alone was infused. BAT DII activity did not decrease with respect to the control value and, in fact, was slightly elevated with the highest T 4 dose infused. In this situation, cerebral cortex and BAT T 3 concentrations were normal or only mildly elevated (cerebral cortex T 3 in Before curve fitting, raw data were transformed into percentages of the mean value of the control group. The 95% confidence interval for the normal plasma TSH concentrations were 77-123% of the mean control values (TSH, 1.02 ng/ml).
a DI, Type I 5Ј-deiodinase; DII, type II 5Ј-deiodinase; DIII, type III 5-deiodinase; BAT, brown adipose tissue. b The curve with the best fitting (defined by the highest r 2 and F values) was selected. Unless otherwise stated, all fittings were significant (P Ͻ 0.05).
animals infused with T 3 ), pointing to mechanisms other than inhibition of DII as those responsible for the protection of brain and BAT against hyperthyroidism. DIII is present in the central nervous system and catalyzes the inactivation of T 4 into rT 3 and that of T 3 into T 2 . Although some researchers have found a decrease in brain DIII activity in hypothyroidism and an increase in hyperthyroidism, with the latter having protective properties against elevated thyroid hormone concentrations (47), we have not been able to confirm these results. Cerebral cortex DIII showed low activities in thyroidectomized rats infused with placebo only in Exp A, not in Exp B and C. Conversely, elevated DIII activity was only found in the groups infused with the higher T 3 doses in Exp C, but not in animals in which hyperthyroidism was induced by the infusion of T 4 . The latter result might be related to a high efficiency of DIII in the degradation of T 4 and T 3 , thus maintaining normal or near-normal tissue T 3 concentrations with minor increases in DIII activity. On the other hand, if T 3 homeostasis is achieved through other regulatory mechanisms, the changes in tissue T 3 might not be enough to induce changes in DIII activity. Other mechanisms not implicating iodothyronine deiodinases, such as reduction in the transthyretin-mediated T 4 transport at the choroid plexus (48) or a decreased T 3 permeability of the blood-brain barrier, might be involved in protection of the cerebral cortex against hyperthyroidism, but do not explain the homeostasis of BAT T 3 or pituitary T 3 .
DI
As expected, DI activity was decreased during hypothyroidism and increased during hyperthyroidism in pituitary, liver, and lung. However, the magnitude of the changes in response to thyroidal status was not the same in all of these tissues, pointing to tissue-specific factors regulating deiodi- nase activity. Moreover, the relationships of iodothyronine deiodinase activity with plasma and tissue thyroid hormones were different depending on which iodothyronine, T 4 or T 3 , was infused.
Pituitary DI activity increases nearly in parallel with pituitary T 3 when either T 4 or T 3 is infused. This finding suggests a regulatory role of pituitary T 3 on pituitary DI activity, in agreement with studies performed in pituitary cells in vitro (49) . With infusion of increasing doses of T 3 , plasma T 3 reached an approximately 5-fold increase with respect to the control value, whereas pituitary T 3 and DI activity only showed 2-fold increases. On the contrary, when T 4 alone was infused, changes in plasma T 3 , pituitary T 3 , and pituitary DI activity were similar. This result is in agreement with previous studies in which most of pituitary T 3 is derived from local conversion of T 4 to T 3 (23, 50) . When T 4 is absent, the only source of pituitary T 3 is the circulating T 3 , and supraphysiological plasma T 3 concentrations must be reached to normalize pituitary T 3 .
Liver DI activity changed in parallel with plasma and tissue T 3 regardless of whether T 4 or T 3 was used as replacement therapy. The highest increases in liver DI activities were reached with the highest T 4 or T 3 dose and were approximately 1.5-fold the simultaneous increases in plasma and liver T 3 . On the contrary, lung DI activity was differentially affected by changes in thyroid hormone concentrations depending on whether T 4 or T 3 was infused. During T 4 infusion, lung DI activity changed in parallel with plasma T 4 and T 3 and tissue T 3 . On the contrary, when T 3 was infused, the increase in lung DI activity was approximately a third of the increase in plasma and lung T 3 . This might result from a stimulatory effect of T 4 or the lung T 3 generated by local conversion from T 4 on lung DI activity and a lack of effect of lung T 3 derived directly from plasma. Other possibilities include an enhanced sulfation of thyroid hormones in lung during T 4 infusion, which, in turn, might stimulate lung DI activity, or a saturation of the stimulatory effect of T 3 on DI activity when very high levels of lung T 3 are reached during T 3 infusion.
Summary
The results of the present study demonstrate that the in vivo regulation of iodothyronine deiodinases in the rat is different depending on the tissue studied. Especially important is the fact that our experimental design has permitted us to study the mechanisms that regulate tissue iodothyronine concentrations under steady state conditions resulting in variable degrees of hypo-or hyperthyroidism. This experimental approach might mimic the physiological and pathological abnormalities of thyroid function better than previous studies performed with single or intermittent injections of T 4 or T 3 .
The present results further support the existence of tissuespecific mechanisms that regulate thyroid hormone concentrations in target tissues (29) . None of the single doses of T 4 or T 3 tested has been able to normalize each iodothyronine deiodinase simultaneously in the tissues in which it was present or even to simultaneously normalize DI and DII in tissues with both activities (i.e. the pituitary). Thus, the pattern of regulation by thyroid hormones of the iodothyronine deiodinases depends on the tissue studied, the iodothyronine infused, its dose, and, possibly, the route of administration, explaining the frequent discrepancies found in the literature regarding this issue. The same occurs with the T 4 and T 3 concentrations in plasma and tissues (29) . On the contrary, tissue concentrations of T 4 and T 3 and iodothyronine deiodinase activities in the tissues studied here reach normal values simultaneously when a combination of 0.9 g T 4 and 0.15 g T 3 /100 g BW⅐day is infused, as previously reported (43) .
According to our present results, tissues with DII activity show a high degree of homeostasis of their T 3 concentrations. The increase in DII activity explains the efficiency of cerebral cortex, BAT, and pituitary in the normalization of tissue T 3 in situations of hypothyroidism, but does not explain the protection against elevated circulating thyroid hormone levels shown by these tissues. The possible role of cortex DIII in this protection has been only partially supported by our data. Finally, as opposed to tissues with DII activity, tissues in which DI activity is preferentially expressed maintain thyroid hormone concentrations similar to those in plasma. This finding might be explained by two nonexclusive hypotheses for such tissues: their thyroid hormone concentrations are in equilibrium with circulating levels and/or the T 3 generated in these tissues is the main source of circulating T 3 .
